ADRENALIN (epinephrine) by Pfizer is adrenergic alpha-agonists [moa]. Approved for anaphylaxis, cardiac arrest. First approved in 2012.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
ADRENALIN (epinephrine) is a small-molecule alpha-adrenergic agonist approved in 2012 for acute, life-threatening conditions including anaphylaxis, cardiac arrest, septic shock, and ventricular fibrillation. It works by stimulating adrenergic receptors to restore blood pressure, cardiac output, and bronchial airflow in emergency settings. The drug is administered via intramuscular, intravenous, or subcutaneous injection.
ADRENALIN is a mature, stable product in peak lifecycle with minimal Part D exposure; commercial teams focus on maintenance and institutional relationships rather than growth.
Adrenergic alpha-Agonists
alpha-Adrenergic Agonist
Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension
Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Pneumatic Leg Compression and Norepinephrine Requirements in Patients Having Non-cardiac Surgery
Treating Intraoperative Bradycardia in Non-cardiac Surgery Patients With Atropine at Heart Rates Below 60 Versus 30 Beats Per Minute and Norepinephrine Requirements
Worked on ADRENALIN at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on ADRENALIN offers stable, essential-medicine positioning within a mature product lifecycle; roles emphasize institutional relationships, guideline management, and supply chain reliability rather than growth marketing. Career trajectory is most suitable for professionals seeking deep expertise in emergency medicine, hospital formularies, and legacy product stewardship.